Literature DB >> 28847991

Dilemma of diagnosing sulphonylurea overdose in children: deliberations and considerations before reaching a diagnosis.

Jaya Sujatha Gopal-Kothandapani1,2, Katherine P Wright3, Sivagamy Sithambaram2,4, Anuja Natarajan5.   

Abstract

A 15-year-old non-diabetic Caucasian girl presented with sudden onset of seizures, unrecordable blood glucose readings and acute renal failure. She denied any medication ingestion and no other precipitating factors were encountered for this acute presentation. She was treated with intravenous glucose infusion and hydrocortisone injection. Investigations showed a non-ketotic hypoglycaemia with high C-peptide and insulin levels. It took several days and multiple investigations to establish the exact cause of her persistent hypoglycaemia before it was concluded to be secondary to gliclazide overdose in a suicide attempt by the young girl. She made a complete recovery in a week with no apparent lasting neurological or renal impairment. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Drugs: Endocrine System; Endocrine System; Paediatrics (drugs And Medicines); Psychiatry (drugs And Medicines); Renal System

Mesh:

Substances:

Year:  2017        PMID: 28847991      PMCID: PMC5614092          DOI: 10.1136/bcr-2017-220044

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  Long-acting sulfonylureas -- long-acting hypoglycaemia.

Authors:  Peter C Veitch; Rory J Clifton-Bligh
Journal:  Med J Aust       Date:  2004-01-19       Impact factor: 7.738

2.  Unwitnessed sulphonylurea poisoning in a healthy toddler.

Authors:  Pei Ying Loo; Fabian Yap
Journal:  Eur J Pediatr       Date:  2010-05-15       Impact factor: 3.183

3.  Severe neuroglycopaenia secondary to severe hypoglycaemia from serendipitous overdose of gliclazide without adrenergic or autonomic response.

Authors:  G R Ling; K Singh; S Y Wong; V K L Toh
Journal:  Diabet Med       Date:  2009-11       Impact factor: 4.359

4.  Acute renal failure after massive ingestion of gliclazide in a suicide attempt.

Authors:  A Barracca; O Ledda; B Michittu; G F Pili; O Manca; A Pani; P Altieri
Journal:  Ren Fail       Date:  1998-05       Impact factor: 2.606

5.  Gliclazide-induced hepatitis, hemiplegia and dysphasia in a suicide attempt.

Authors:  H Caksen; M Kendirci; A Tutuş; K Uzüm; S Kurtoğlu
Journal:  J Pediatr Endocrinol Metab       Date:  2001 Sep-Oct       Impact factor: 1.634

6.  Octreotide: an antidote for sulfonylurea-induced hypoglycemia.

Authors:  S A McLaughlin; C S Crandall; P E McKinney
Journal:  Ann Emerg Med       Date:  2000-08       Impact factor: 5.721

7.  HEADSS, a psychosocial risk assessment instrument: implications for designing effective intervention programs for runaway youth.

Authors:  E Cohen; R G Mackenzie; G L Yates
Journal:  J Adolesc Health       Date:  1991-11       Impact factor: 5.012

8.  Neuroglycopenia and adrenergic responses to hypoglycaemia: insights from a local epidemic of serendipitous massive overdose of glibenclamide.

Authors:  R Dalan; M K S Leow; J George; K Y Chian; A Tan; H W Han; S P Cheow
Journal:  Diabet Med       Date:  2009-01       Impact factor: 4.359

9.  International prevalence of adolescent non-suicidal self-injury and deliberate self-harm.

Authors:  Jennifer J Muehlenkamp; Laurence Claes; Lindsey Havertape; Paul L Plener
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2012-03-30       Impact factor: 3.033

Review 10.  Octreotide for the treatment of sulfonylurea poisoning.

Authors:  Miguel Glatstein; Dennis Scolnik; Yedidia Bentur
Journal:  Clin Toxicol (Phila)       Date:  2012-10-10       Impact factor: 4.467

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.